about
DNA array analysis of interleukin-2-regulated immediate/early genesThe quantal theory of how the immune system discriminates between "self and non-self"Interleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative studyApplication of IL-2 therapy to target T regulatory cell functionModel of DNA dynamics and replicationLong Range Force between Pre-Replication Complexes (Pre-RC) in DNA Controls Replication and Cell Cycle ProgressionDNA Replication and Cell Cycle Progression Regulatedby Long Range Interaction between Protein Complexes bound to DNAcDNA cloning of porcine interleukin-2 receptor-alpha gene.Negative feedback regulation of T cells via interleukin-2 and FOXP3 reciprocity.CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production.A promoter element that exerts positive and negative control of the interleukin 2-responsive J-chain gene.Evaluation of a quantitative real-time PCR assay to measure HIV-specific mucosal CD8+ T cell responses in the cervix.Erythropoietin receptor: cloning strategy and structural features.Implications of epidermal growth factor (EGF) induced egf receptor aggregationFailure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy.Effects of opioids on the immune system.Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.Mechanistic model of natural killer cell proliferative response to IL-15 receptor stimulationX-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis.Rational immunotherapy with interleukin 2.Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancerIdentification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain.Strategies for improving antitumor activity utilizing IL-2: preclinical models and analysis of antitumor activity of lymphocytes from patients receiving IL-2.Determining to divide: how do cells decide?Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptorsThe quantal theory of immunity.Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: chromosomal mapping and tissue specificity of IL-2R gamma chain expression.Interaction between NF-kappa B- and serum response factor-binding elements activates an interleukin-2 receptor alpha-chain enhancer specifically in T lymphocytes.Interleukin-2-triggered Raf-1 expression, phosphorylation, and associated kinase activity increase through G1 and S in CD3-stimulated primary human T cells.DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic responseCharacterization of the human interleukin-2 receptor beta-chain gene promoter: regulation of promoter activity by ets gene productsInterleukin (IL)-2 and IL-3 induce distinct but overlapping responses in murine IL-3-dependent 32D cells transduced with human IL-2 receptor beta chain: involvement of tyrosine kinase(s) other than p56lck.Interleukin-2 receptor signaling in regulatory T cell development and homeostasisFollowing the cytokine signaling pathway to leukemogenesis: a chronologyTwo sites in the tissue factor extracellular domain mediate the recognition of the ligand factor VIIa.Erythropoietin receptor. Subunit structure and activation.Interleukin-2 in the treatment of HIV disease.
P2860
Q24799770-995E8502-30B8-42EF-90F4-5A2C313A0E54Q24803143-04429A49-DA78-46F1-9696-BE81EECDE131Q24803779-55A29A17-3B95-434E-8019-56AB1779BA32Q26827327-04A510C3-7E6E-4404-A5CB-E3593EA10C1DQ30458942-DFC8D5AB-4264-4AD2-A23A-4EAA8870FE1BQ30458948-1DEAD49F-F830-4149-B652-6CE36720B857Q30458953-2D215EFD-5E63-497F-9C38-07823AF62CB5Q32146649-E3B99ABA-A8AB-46D1-B8B9-90F15E6BE6B5Q33322892-3F34ABC3-5474-4ADC-A2D9-FB46497E9CE8Q33559655-2D18184E-5E92-4230-807A-BF24B2E01819Q33611936-838FEB0F-8005-429E-A6FA-300D134C4EA1Q33719485-FEBE6BEE-FF59-485C-9371-6C1CECF79DDFQ33902213-D2B032C3-6748-4293-B1ED-9BDF24F0341CQ34091453-0259B425-B690-4D9E-8DE4-9D998B3E096BQ34257060-DB28FA0F-6944-4B90-9C03-DC93951124D2Q34409796-4FE82BE4-2994-4459-ADDD-AB46F3D0C50AQ34979517-CD665A7D-E6CE-4F5B-9D33-35ECD0863081Q34998162-197A4626-4FD0-49D0-B8F9-3D29F13D43A1Q35224827-C6EB3427-43B4-4249-BA4B-B90D2CAE1793Q35300674-E6772A77-2D7F-47A3-BCD2-EC032BC8ED5FQ35357417-A3267A03-353D-4DD8-A79D-146B826D7C90Q35553553-10379856-9243-479E-BD19-972F9CA482B9Q35823805-36545B0F-C95B-4AD2-B582-A828EA9323B2Q35982247-8C69A98A-2540-4E24-B118-D7120FF66255Q36174744-EF380418-6C91-48C7-B6FF-1F88E3947A0CQ36184041-B4FB9EDA-49B5-412A-90A7-8ACD0753F6B8Q36273854-E3A33A24-6C43-4F18-B1AD-0B60707922E6Q36351101-74E03DD7-36F9-4172-A645-E18D583610E1Q36391829-357C688C-FA88-4172-9F57-10F3892714EFQ36534111-CC86825F-96D2-4A2A-B229-A56AE0F04D74Q36679345-B1F41FB3-0A5E-4E60-B36D-121F14B55717Q36693236-5275099B-2E35-4A05-84B9-37AA6143F20DQ36752152-EBD1D770-546B-4A47-B7E1-1427AE1572D6Q36823531-8EC97D2C-74B1-49BA-B007-DA7E5E118DDFQ36921940-980B049E-2A46-4DB5-98CB-A8231A2D8DF4Q36971446-EC92360B-14E5-4F91-BFA2-7398BD3435ACQ37316601-7B374B46-25CE-4887-AE8A-7F3DC0F6B3E3Q37597506-BBF160AC-C448-4BBC-8C1C-B53DC42ADE92Q37891482-92040691-F1AE-4154-8A26-EF5F058EF4ADQ37952622-8F401DED-9F1E-43AB-9610-69180748352E
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
The interleukin 2 receptor.
@en
type
label
The interleukin 2 receptor.
@en
prefLabel
The interleukin 2 receptor.
@en
P1476
The interleukin 2 receptor.
@en
P2093
P304
P356
10.1146/ANNUREV.CB.05.110189.002145
P577
1989-01-01T00:00:00Z